Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
6.95
-0.28 (-3.87%)
At close: Nov 4, 2025, 4:00 PM EST
7.54
+0.59 (8.49%)
After-hours: Nov 4, 2025, 7:59 PM EST
Niagen Bioscience Employees
Niagen Bioscience had 104 employees as of December 31, 2024. The number of employees decreased by 2 or -1.89% compared to the previous year.
Employees
104
Change (1Y)
-2
Growth (1Y)
-1.89%
Revenue / Employee
$1,199,125
Profits / Employee
$196,433
Market Cap
555.44M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 104 | -2 | -1.89% |
| Dec 31, 2023 | 106 | -7 | -6.19% |
| Dec 31, 2022 | 113 | -2 | -1.74% |
| Dec 31, 2021 | 115 | 5 | 4.55% |
| Dec 31, 2020 | 110 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 2, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NAGE News
- 3 hours ago - Niagen Bioscience, Inc. (NAGE) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 6 hours ago - Niagen Bioscience, Inc. Reports Third Quarter 2025 Financial Results and Reaffirms Increased Full Year Outlook - Business Wire
- 14 days ago - Niagen Bioscience to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025 - Business Wire
- 4 weeks ago - Niagen Bioscience Increases Full Year 2025 Net Sales Outlook to 25% to 30% Year-Over-Year Growth - Business Wire
- 4 weeks ago - Niagen Bioscience's Pharmaceutical-Grade Niagen™ IV and Injections Now Available at over 50 iCRYO Clinics and More than 900 Total Clinics Nationwide - Business Wire
- 7 weeks ago - AboutNADⓇ Debuts as the Leading Online Resource for Scientific Advancements in NAD+ - Business Wire
- 3 months ago - Niagen Bioscience, Inc. Reports Second Quarter 2025 Financial Results and Increases Full Year Outlook - Business Wire
- 3 months ago - Niagen Bioscience to Present at Canaccord Genuity's 45th Annual Growth Conference - Business Wire